课题基金 / 基金详情

Bleeding, transfusion, and the use of anticoagulants in patients with critical illness: Generating evidence to inform practice change and improve outcomes

Bleeding, transfusion, and the use of anticoagulants in patients with critical illness: Generating evidence to inform practice change and improve outcomes
危重患者的出血、输血和抗凝剂的使用:生成证据以告知实践改变和改善结果
批准号:
302242
负责人:
Zarychanski Ryan
金额:
$21.86万
依托单位:
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-12-01 至 2018-12-01

项目摘要

项目成果

Zarychanski Ryan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bleeding and transfusion of blood products are associated with adverse events and poor outcomes compared to those who do not require blood. Blood is also a scare donor resource that must be preserved. In critically ill patients who are severely bleeding,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)
  • 批准号:
    463407
  • 项目类别:
    Operating Grants
  • 资助金额:
    $288.63万
  • 财政年份:
    2022
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
ANTI-THROMBOTIC THERAPY TO AMELIORATE COMPLICATIONS OF COVID-19 (ATTACC): A randomized, international, multi-centre, adaptive, controlled clinical trial
  • 批准号:
    429655
  • 项目类别:
    Operating Grants
  • 资助金额:
    $260.32万
  • 财政年份:
    2020
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
  • 批准号:
    405787
  • 项目类别:
    Operating Grants
  • 资助金额:
    $174.34万
  • 财政年份:
    2019
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Tranexamic acid to reduce red blood cell transfusion in major non-cardiac surgery (TRACTION): A pragmatic, registry-based, pilot, randomized controlled trial
  • 批准号:
    398808
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2018
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
海外基金